Member Exclusive Journal content

Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden

In this article, published in Future Oncology, researchers from Sweden and Switzerland have investigated the pattern of implementation of subcutaneous trastuzumab and the switching rate between the two formulations in a real-world setting using data from three nonacademic hospitals in Sweden.

Go to the profile of Future Oncology
Nov 20, 2019
0
0

Please sign in or register for FREE

No comments yet.